Los Angeles, CA96 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Los Angeles, CA

Find 96 actively recruiting myalgic encephalomyelitis clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

96
Active Trials
77
Sponsors
48,943
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Los Angeles

About Myalgic Encephalomyelitis Clinical Trials in Los Angeles

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 96 myalgic encephalomyelitis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 48,943 participants. Research is being sponsored by Duke University, Melanoma and Skin Cancer Trials Limited, Healthy Minds Initiative and 74 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Los Angeles — FAQ

Are there myalgic encephalomyelitis clinical trials in Los Angeles?

Yes, there are 96 myalgic encephalomyelitis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 96 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 20, 2026 from ClinicalTrials.gov